{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:38:32Z","timestamp":1790095112483,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018619","name":"National Program for Support of Top-notch Young Professionals","doi-asserted-by":"publisher","award":["BJ2023089"],"award-info":[{"award-number":["BJ2023089"]}],"id":[{"id":"10.13039\/501100018619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","award":["Z202016"],"award-info":[{"award-number":["Z202016"]}],"id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016308","name":"Wuxi Health and Family Planning Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020771","name":"Natural Science Foundation for Young Scientists of Shanxi Province","doi-asserted-by":"publisher","award":["BK BK20230189"],"award-info":[{"award-number":["BK BK20230189"]}],"id":[{"id":"10.13039\/501100020771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008109","name":"Wuxi Municipal Bureau on Science and Technology","doi-asserted-by":"publisher","award":["K20221033"],"award-info":[{"award-number":["K20221033"]}],"id":[{"id":"10.13039\/501100008109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.micpath.2024.106865","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T06:25:22Z","timestamp":1723703122000},"page":"106865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Exploring the pathogenicity of Mycoplasma pneumoniae: Focus on community-acquired respiratory distress syndrome toxins"],"prefix":"10.1016","volume":"195","author":[{"given":"Nuo","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7487-135X","authenticated-orcid":false,"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8107-0507","authenticated-orcid":false,"given":"Yun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"48","key":"10.1016\/j.micpath.2024.106865_bib1","doi-asserted-by":"crossref","first-page":"30547","DOI":"10.1073\/pnas.2013182117","article-title":"The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections","volume":"117","author":"Baker","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.micpath.2024.106865_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1473-3099(22)00544-8","article-title":"Quantifying the RSV immunity debt following COVID-19: a public health matter","volume":"23","author":"Billard","year":"2023","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.micpath.2024.106865_bib3","doi-asserted-by":"crossref","first-page":"e2829","DOI":"10.1093\/cid\/ciaa1906","article-title":"The interseasonal resurgence of respiratory syncytial virus in Australian children following the reduction of coronavirus disease 2019-related public health measures","volume":"73","author":"Foley","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2024.106865_bib4","series-title":"Disclosure: John Kiel Declares No Relevant Financial Relationships with Ineligible Companies","article-title":"Mycoplasma pneumonia, StatPearls, treasure island (FL) ineligible companies","author":"Abdulhadi","year":"2023"},{"issue":"8","key":"10.1016\/j.micpath.2024.106865_bib5","first-page":"449","article-title":"Clinical characteristics of patients with Mycoplasma pneumoniae infection","volume":"40","author":"Alvaro Varela","year":"2022","journal-title":"Enferm. Infecc. Microbiol. Cl\u00edn."},{"issue":"1","key":"10.1016\/j.micpath.2024.106865_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12879-022-07263-z","article-title":"Analysis of national surveillance of respiratory pathogens for community-acquired pneumonia in children and adolescents","volume":"22","author":"Roh","year":"2022","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.micpath.2024.106865_bib7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma pneumoniae from the respiratory tract and beyond","volume":"30","author":"Waites","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.micpath.2024.106865_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00284-022-03103-0","article-title":"Insight into the pathogenic mechanism of mycoplasma pneumoniae","volume":"80","author":"Hu","year":"2023","journal-title":"Curr. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2024.106865_bib9","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1128\/IAI.73.5.2828-2834.2005","article-title":"Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae","volume":"73","author":"Kannan","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2024.106865_bib10","series-title":"ADP-Ribosylating and Vacuolating Cytotoxin of: Mycoplasma","author":"Kannan","year":"2006"},{"issue":"16","key":"10.1016\/j.micpath.2024.106865_bib11","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1073\/pnas.1420308112","article-title":"Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae","volume":"112","author":"Becker","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.micpath.2024.106865_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022877","article-title":"Cellular vacuoles induced by Mycoplasma pneumoniae CARDS toxin originate from Rab9-associated compartments","volume":"6","author":"Johnson","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.micpath.2024.106865_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01497-14","article-title":"Annexin A2 mediates Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin binding to eukaryotic cells","volume":"5","author":"Somarajan","year":"2014","journal-title":"mBio"},{"issue":"5","key":"10.1016\/j.micpath.2024.106865_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062706","article-title":"Mycoplasma pneumoniae CARDS toxin is internalized via clathrin-mediated endocytosis","volume":"8","author":"Krishnan","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.micpath.2024.106865_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01663-17","article-title":"Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin uses a novel KELED sequence for retrograde transport and subsequent cytotoxicity","volume":"9","author":"Ramasamy","year":"2018","journal-title":"mBio"},{"issue":"5","key":"10.1016\/j.micpath.2024.106865_bib16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1365-2958.2010.07092.x","article-title":"Mycoplasma pneumoniae community acquired respiratory distress syndrome toxin expression reveals growth phase and infection\u2010dependent regulation","volume":"76","author":"Kannan","year":"2010","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.micpath.2024.106865_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbrc.2022.01.058","article-title":"Vaccine using community-acquired respiratory distress syndrome toxin as an antigen against Mycoplasma pneumoniae in mice","volume":"594","author":"Yoshikawa","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.micpath.2024.106865_bib18","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/infdis\/jir557","article-title":"Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model","volume":"204","author":"Kannan","year":"2011","journal-title":"JID (J. Infect. Dis.)"},{"issue":"3","key":"10.1016\/j.micpath.2024.106865_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1128\/AAC.01164-10","article-title":"Newly discovered and characterized antivirulence compounds inhibit bacterial mono-ADP-ribosyltransferase toxins","volume":"55","author":"Turgeon","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2024.106865_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.it.2018.12.006","article-title":"Regulating immunity via ADP-ribosylation: therapeutic implications and beyond","volume":"40","author":"Kunze","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.micpath.2024.106865_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ab.2017.10.025","article-title":"An ELISA method to estimate the mono ADP-ribosyltransferase activities: eg in pertussis toxin and vaccines","volume":"540","author":"Asokanathan","year":"2018","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.micpath.2024.106865_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/imm.13332","article-title":"ADP\u2010ribosylation in evasion, promotion and exacerbation of immune responses","volume":"164","author":"Rosado","year":"2021","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.micpath.2024.106865_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02186-14","article-title":"ADP-ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS toxin regulates inflammasome activity","volume":"5","author":"Bose","year":"2014","journal-title":"mBio"},{"issue":"10","key":"10.1016\/j.micpath.2024.106865_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007562","article-title":"Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin","volume":"4","author":"Hardy","year":"2009","journal-title":"PLoS One"},{"issue":"34","key":"10.1016\/j.micpath.2024.106865_bib25","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.10150","article-title":"Cytoplasmic vacuolization in cell death and survival","volume":"7","author":"Shubin","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.micpath.2024.106865_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90948-3","article-title":"Mycoplasma pneumoniae CARDS toxin exploits host cell endosomal acidic pH and vacuolar ATPase proton pump to execute its biological activities","volume":"11","author":"Ramasamy","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2024.106865_bib27","first-page":"1","article-title":"Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms","author":"Sharndama","year":"2022","journal-title":"Braz. J. Microbiol."},{"key":"10.1016\/j.micpath.2024.106865_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fmicb.2016.00414","article-title":"Inflammation-inducing factors of Mycoplasma pneumoniae","volume":"7","author":"Shimizu","year":"2016","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2024.106865_bib29","article-title":"NLRP3 is a critical regulator of inflammation and innate immune cell response during mycoplasma pneumoniae infection","volume":"86","author":"Ja","year":"2017","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.micpath.2024.106865_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/imm.13309","article-title":"Enigmatic inflammasomes","volume":"162","author":"Triantafilou","year":"2021","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.micpath.2024.106865_bib31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.micpath.2024.106865_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118149","article-title":"Interleukin-23 derived from CD16+ monocytes drives IL-17 secretion by TLR4 pathway in children with mycoplasma pneumoniae pneumonia","volume":"258","author":"Wang","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.micpath.2024.106865_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13052-022-01254-1","article-title":"Investigation of the relationship between community-acquired respiratory distress syndrome toxin and the high-mobility group box protein 1-toll-like receptors-myeloid differentiation factor 88 signaling pathway in Mycoplasma pneumoniae pneumonia","volume":"48","author":"Fan","year":"2022","journal-title":"Ital. J. Pediatr."},{"issue":"6","key":"10.1016\/j.micpath.2024.106865_bib34","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1165\/rcmb.2011-0135OC","article-title":"Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation","volume":"46","author":"Medina","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.micpath.2024.106865_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1165\/rcmb.2017-0006OC","article-title":"The immunopathologic effects of Mycoplasma pneumoniae and community-acquired respiratory distress syndrome toxin. A primate model","volume":"58","author":"Maselli","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"9","key":"10.1016\/j.micpath.2024.106865_bib36","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1164\/rccm.200412-1743PP","article-title":"Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?","volume":"172","author":"Johnston","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.micpath.2024.106865_bib37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1378\/chest.10-1222","article-title":"Novel toxin assays implicate Mycoplasma pneumoniae in prolonged ventilator course and hypoxemia","volume":"139","author":"Muir","year":"2011","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.micpath.2024.106865_bib38","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/all.14696","article-title":"Corrigendum for:\" Protein S protects against allergic bronchial asthma by modulating Th1\/Th2 balance","volume":"76","author":"Asayama","year":"2021","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.micpath.2024.106865_bib39","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaci.2015.09.032","article-title":"Incident asthma and Mycoplasma pneumoniae: a nationwide cohort study","volume":"137","author":"Yeh","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.micpath.2024.106865_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172447","article-title":"Mycoplasma pneumoniae CARDS toxin elicits a functional IgE response in Balb\/c mice","volume":"12","author":"Medina","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.micpath.2024.106865_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102613","article-title":"Mycoplasma pneumoniae CARDS toxin exacerbates ovalbumin-induced asthma-like inflammation in BALB\/c mice","volume":"9","author":"Medina","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.micpath.2024.106865_bib42","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1111\/j.1365-2222.2009.03309.x","article-title":"A low dose of Mycoplasma pneumoniae infection enhances an established allergic inflammation in mice: the role of the prostaglandin E2 pathway","volume":"39","author":"Wu","year":"2009","journal-title":"Clin. Exp. Allergy"},{"issue":"2","key":"10.1016\/j.micpath.2024.106865_bib43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.11-0221","article-title":"Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma","volume":"140","author":"Peters","year":"2011","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.micpath.2024.106865_bib44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.anai.2013.01.022","article-title":"Mycoplasma pneumoniae in children with acute and refractory asthma","volume":"110","author":"Wood","year":"2013","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"7","key":"10.1016\/j.micpath.2024.106865_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.20949","article-title":"Global Trends in the proportion of macrolide-resistant Mycoplasma pneumoniae infections: a systematic review and meta-analysis","volume":"5","author":"Kim","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"32","key":"10.1016\/j.micpath.2024.106865_bib46","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1016\/j.vaccine.2020.05.074","article-title":"Vaccination using inactivated Mycoplasma pneumoniae induces detrimental infiltration of neutrophils after subsequent infection in mice","volume":"38","author":"Tamiya","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.micpath.2024.106865_bib47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41541-022-00556-z","article-title":"B cells oppose M ycoplasma pneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs","volume":"7","author":"Gavitt","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.micpath.2024.106865_bib48","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s10096-021-04209-2","article-title":"Evaluation of the CARDS toxin and its fragment for the serodiagnosis of Mycoplasma pneumoniae infections","volume":"40","author":"Xue","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"6","key":"10.1016\/j.micpath.2024.106865_bib49","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1164\/rccm.201001-0080OC","article-title":"Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains","volume":"182","author":"Techasaensiri","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.micpath.2024.106865_bib50","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1128\/IAI.00044-09","article-title":"Characterization of a unique ADP-ribosyltransferase of Mycoplasma penetrans","volume":"77","author":"Johnson","year":"2009","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.micpath.2024.106865_bib51","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2009.09.094","article-title":"A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use","volume":"28","author":"Wagner","year":"2009","journal-title":"Vaccine"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401024003322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401024003322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T11:07:08Z","timestamp":1726312028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401024003322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":51,"alternative-id":["S0882401024003322"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2024.106865","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the pathogenicity of Mycoplasma pneumoniae: Focus on community-acquired respiratory distress syndrome toxins","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2024.106865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106865"}}